Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy
- PMID: 28761402
- PMCID: PMC5505400
- DOI: 10.14503/THIJ-15-5007
Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy
Abstract
Posterior reversible encephalopathy syndrome, an infrequent neurotoxicity associated with the use of tacrolimus, was first described in 1996, as a reversible syndrome manifested by headache, altered mental function, seizures, and visual disturbances. We describe the case of a 37-year-old woman who developed neurologic symptoms consistent with encephalopathy after treatment with tacrolimus, which was prescribed to maintain immunosuppression after orthotopic heart transplantation. This report also discusses the imaging methods used in the diagnosis of posterior reversible encephalopathy and highlights the difficulty of maintaining immunosuppression and managing medication-related adverse effects, while taking into account the risk of acute rejection after transplantation.
Keywords: Brain diseases/diagnostic imaging; drug therapy, combination; graft rejection/heart transplantation/adverse effects; immunosuppressive agents/therapeutic use; nervous system diseases/chemically induced; tacrolimus/adverse effects/therapeutic use; treatment outcome.
Figures
References
-
- Kou R, Greif D, Michel T.. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002; 277 33: 29669– 73. - PubMed
-
- Baran DA, Zucker MJ, Arroyo LH, Camacho M, Goldschmidt ME, Nicholls SJ, . et al. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail 2011; 4 2: 129– 37. - PubMed
-
- Colombo D, Ammirati E.. Cyclosporine in transplantation - a history of converging timelines. J Biol Regul Homeost Agents 2011; 25 4: 493– 504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
